Keyphrases
AIDS/HIV
80%
Older Women
50%
Psychosis
40%
Hematemesis
40%
Poisoning
40%
Partial Thromboplastin Time
40%
Vitamin K
40%
Superwarfarin
40%
Angioedema
40%
Hypothyroidism
40%
Tophaceous Gout
40%
Tenofovir
40%
Cutaneous Reaction
40%
Tenofovir Disoproxil Fumarate
40%
Amphotericin B
40%
Non-adherence
40%
Rheumatoid Arthritis
40%
Randomized Controlled Trial
40%
Treatment Adherence
40%
HIV Status
40%
Fragility Index
40%
Prothrombin Time
26%
International Normalized Ratio
26%
Chronic Gout
26%
Gouty Arthritis
26%
Risk of Bias
26%
Comorbid
20%
Treatment Issues
20%
Antiretroviral Adherence
20%
Psychotic Symptoms
20%
Trunk
20%
HIV Clinics
20%
Maculopapular Rash
20%
Type IV Hypersensitivity
20%
Early Discontinuation
20%
Indigent Care
20%
Therapy Discontinuation
20%
Immunological Mechanisms
20%
HIV Infection
20%
Adverse Drug Reaction
20%
Legal Issues
20%
Psychiatric Illness
20%
Ethical Issues
20%
Fragility Quotient
20%
HIV Patients
20%
Histoplasmosis
13%
Amphotericin B Deoxycholate
13%
American Indian Women
13%
Oral Administration
13%
HIV Medicine
13%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Bleeding
40%
Thromboplastin
40%
Angioneurotic Edema
40%
Hypothyroidism
40%
Erethism
40%
Skin Manifestation
40%
Tenofovir
40%
Tenofovir Disoproxil
40%
Amphotericin B
40%
Vitamin K Group
40%
Hematemesis
40%
Prothrombin
40%
Toxic Injury
40%
Adverse Drug Reaction
20%
Maculopapular Rash
20%
Human Immunodeficiency Virus Infection
20%
Allergic Reaction
20%
Blood Clotting Factor
13%
Histoplasma
13%
Amphotericin B Deoxycholate
13%
Toxicity
13%
Filobasidiella
13%
Ajellomyces capsulatus
13%
Fresh Frozen Plasma
13%
Systemic Mycosis
13%
Brodifacoum
13%
Rodenticide
13%
Ecchymosis
13%
Chronic Urticaria
10%
Urticaria
10%
Combination Therapy
10%
Medicine and Dentistry
Human Immunodeficiency Virus
60%
Hypothyroidism
40%
Angioedema
40%
Tenofovir
40%
Tenofovir Disoproxil
40%
Skin Manifestation
40%
Inflammatory Arthritis
40%
Patient Compliance
26%
Maculopapular Rash
20%
Human Immunodeficiency Virus Infection
20%
Hypersensitivity
20%
Allergic Response
20%
Type IV Hypersensitivity
20%
Adverse Drug Reaction
20%
Antiretroviral Therapy
13%
Airway Management
10%
Chronic Urticaria
10%
Urticaria
10%
Combination Therapy
10%
Emergency Department
10%